295 related articles for article (PubMed ID: 32184181)
1. Inpatient burden and resource utilization of polymyositis and dermatomyositis: A 10-year Study of National Inpatient Sample.
Ungprasert P; Wannarong T; Cheungpasitporn W; Wijarnpreecha K; Thongprayoon C; Kroner PT
Joint Bone Spine; 2020 Jul; 87(4):327-330. PubMed ID: 32184181
[TBL] [Abstract][Full Text] [Related]
2. Inpatient burden and association with comorbidities of polyarteritis nodosa: National Inpatient Sample 2014.
Ungprasert P; Koster MJ; Cheungpasitporn W; Wijarnpreecha K; Thongprayoon C; Kroner PT
Semin Arthritis Rheum; 2020 Feb; 50(1):66-70. PubMed ID: 31362895
[TBL] [Abstract][Full Text] [Related]
3. Reasons for Hospitalization and In-Hospital Mortality in Adults With Dermatomyositis and Polymyositis.
Pavon MR; Sanchez JE; Pescatore J; Edigin E; Richardson C; Manadan A
J Clin Rheumatol; 2022 Mar; 28(2):e433-e439. PubMed ID: 34262001
[TBL] [Abstract][Full Text] [Related]
4. A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositis.
Murray SG; Schmajuk G; Trupin L; Lawson E; Cascino M; Barton J; Margaretten M; Katz PP; Yelin EH; Yazdany J
Arthritis Care Res (Hoboken); 2015 May; 67(5):673-80. PubMed ID: 25331828
[TBL] [Abstract][Full Text] [Related]
5. Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: A retrospective case-control study.
Wu C; Wang Q; He L; Yang E; Zeng X
PLoS One; 2018; 13(2):e0192491. PubMed ID: 29474373
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study.
Chung WS; Lin CL; Sung FC; Lu CC; Kao CH
Thromb Res; 2014 Sep; 134(3):622-6. PubMed ID: 25034321
[TBL] [Abstract][Full Text] [Related]
7. Polymyositis/dermatomyositis readmissions: analysis of the nationwide readmission database.
Idolor O; Edigin E; Hino C; He E; Rao J; Ugoh AC; Onobraigho P; Omoike E; Okpujie V; Ezeafulukwe CJ; Eseaton PO; Manadan A; Downey C
Clin Rheumatol; 2023 Oct; 42(10):2833-2839. PubMed ID: 37407906
[TBL] [Abstract][Full Text] [Related]
8. Inpatient Prevalence, Expenditures, and Comorbidities of Sarcoidosis: Nationwide Inpatient Sample 2013-2014.
Ungprasert P; Wijarnpreecha K; Cheungpasitporn W; Thongprayoon C; Manatsathit W; Kröner PT
Lung; 2019 Apr; 197(2):165-171. PubMed ID: 30798420
[TBL] [Abstract][Full Text] [Related]
9. Inpatient prevalence, burden and comorbidity of Takayasu's arteritis: Nationwide inpatient sample 2013-2014.
Ungprasert P; Wijarnpreecha K; Cheungpasitporn W; Thongprayoon C; Kroner PT
Semin Arthritis Rheum; 2019 Aug; 49(1):136-139. PubMed ID: 30577953
[TBL] [Abstract][Full Text] [Related]
10. Healthcare resource utilization and work loss in dermatomyositis and polymyositis patients in a privately-insured US population.
Bradford Rice J; White A; Lopez A; Galebach P; Schepman P; Popelar B; Philbin M
J Med Econ; 2016 Jul; 19(7):649-54. PubMed ID: 26850074
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort.
Dobloug C; Garen T; Bitter H; Stjärne J; Stenseth G; Grøvle L; Sem M; Gran JT; Molberg Ø
Ann Rheum Dis; 2015 Aug; 74(8):1551-6. PubMed ID: 24695011
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy outcomes in adult patients with dermatomyositis and polymyositis.
Kolstad KD; Fiorentino D; Li S; Chakravarty EF; Chung L
Semin Arthritis Rheum; 2018 Jun; 47(6):865-869. PubMed ID: 29217291
[TBL] [Abstract][Full Text] [Related]
13. Epidemiologic analysis of the clinical features of Japanese patients with polymyositis and dermatomyositis.
Tomimitsu H; Ohta A; Nagai M; Nishina M; Ishihara S; Kohsaka H
Mod Rheumatol; 2016; 26(3):398-402. PubMed ID: 26375202
[TBL] [Abstract][Full Text] [Related]
14. Inpatient epidemiology and economic burden of granulomatosis with polyangiitis: a 10-year study of the national inpatient sample.
Ungprasert P; Koster MJ; Cheungpasitporn W; Wijarnpreecha K; Thongprayoon C; Kroner PT
Rheumatology (Oxford); 2020 Dec; 59(12):3685-3689. PubMed ID: 32129858
[TBL] [Abstract][Full Text] [Related]
15. Traditional cardiovascular risk factors and coronary artery calcification in adults with polymyositis and dermatomyositis: a Danish multicenter study.
Diederichsen LP; Diederichsen AC; Simonsen JA; Junker P; Søndergaard K; Lundberg IE; Tvede N; Gerke O; Christensen AF; Dreyer L; Petersen H; Ejstrup L; Kay SD; Jacobsen S
Arthritis Care Res (Hoboken); 2015 May; 67(6):848-54. PubMed ID: 25418360
[TBL] [Abstract][Full Text] [Related]
16. Inpatient burden of juvenile dermatomyositis among children in the United States.
Kwa MC; Silverberg JI; Ardalan K
Pediatr Rheumatol Online J; 2018 Nov; 16(1):70. PubMed ID: 30424778
[TBL] [Abstract][Full Text] [Related]
17. Disease burden and treatment sequence of polymyositis and dermatomyositis patients in Japan: a real-world evidence study.
Miyazaki C; Ishii Y; Stelmaszuk NM
Clin Rheumatol; 2022 Mar; 41(3):741-755. PubMed ID: 34677707
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hearing loss, tinnitus, vertigo and sudden deafness among patients with polymyositis and dermatomyositis.
Hung SH; Xirasagar S; Dang LH; Viet-Nhi NK; Cheng YF; Chen CS; Lin HC
Sci Rep; 2024 Mar; 14(1):5774. PubMed ID: 38459190
[TBL] [Abstract][Full Text] [Related]
19. Inpatient epidemiology, healthcare utilization, and association with comorbidities of Turner syndrome: A National Inpatient Sample study.
Chenbhanich J; Ungprasert P; Kroner PT
Am J Med Genet A; 2023 Jul; 191(7):1870-1877. PubMed ID: 37132414
[TBL] [Abstract][Full Text] [Related]
20. Reappraisal of the incidence, various types and risk factors of malignancies in patients with dermatomyositis and polymyositis in Taiwan.
Hsu JL; Liao MF; Chu CC; Kuo HC; Lyu RK; Chang HS; Chen CM; Wu YR; Chang KH; Weng YC; Chang CW; Chiang HI; Cheng CK; Lee PW; Huang CC; Ro LS
Sci Rep; 2021 Feb; 11(1):4545. PubMed ID: 33633147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
